Antidiabetic Thiazolidinediones - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

The global market for Antidiabetic Thiazolidinediones was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Antidiabetic Thiazolidinediones, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Antidiabetic Thiazolidinediones by region & country, by Type, and by Application.

The Antidiabetic Thiazolidinediones market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antidiabetic Thiazolidinediones.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antidiabetic Thiazolidinediones manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Antidiabetic Thiazolidinediones in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Antidiabetic Thiazolidinediones in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Antidiabetic Thiazolidinediones Product Introduction
    1.2 Global Antidiabetic Thiazolidinediones Market Size Forecast
        1.2.1 Global Antidiabetic Thiazolidinediones Sales Value (2019-2030)
        1.2.2 Global Antidiabetic Thiazolidinediones Sales Volume (2019-2030)
        1.2.3 Global Antidiabetic Thiazolidinediones Sales Price (2019-2030)
    1.3 Antidiabetic Thiazolidinediones Market Trends & Drivers
        1.3.1 Antidiabetic Thiazolidinediones Industry Trends
        1.3.2 Antidiabetic Thiazolidinediones Market Drivers & Opportunity
        1.3.3 Antidiabetic Thiazolidinediones Market Challenges
        1.3.4 Antidiabetic Thiazolidinediones Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Antidiabetic Thiazolidinediones Players Revenue Ranking (2023)
    2.2 Global Antidiabetic Thiazolidinediones Revenue by Company (2019-2024)
    2.3 Global Antidiabetic Thiazolidinediones Players Sales Volume Ranking (2023)
    2.4 Global Antidiabetic Thiazolidinediones Sales Volume by Company Players (2019-2024)
    2.5 Global Antidiabetic Thiazolidinediones Average Price by Company (2019-2024)
    2.6 Key Manufacturers Antidiabetic Thiazolidinediones Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Antidiabetic Thiazolidinediones Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Antidiabetic Thiazolidinediones
    2.9 Antidiabetic Thiazolidinediones Market Competitive Analysis
        2.9.1 Antidiabetic Thiazolidinediones Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Antidiabetic Thiazolidinediones Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antidiabetic Thiazolidinediones as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Rosiglitazone
        3.1.2 Pioglitazone
    3.2 Global Antidiabetic Thiazolidinediones Sales Value by Type
        3.2.1 Global Antidiabetic Thiazolidinediones Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Antidiabetic Thiazolidinediones Sales Value, by Type (2019-2030)
        3.2.3 Global Antidiabetic Thiazolidinediones Sales Value, by Type (%) (2019-2030)
    3.3 Global Antidiabetic Thiazolidinediones Sales Volume by Type
        3.3.1 Global Antidiabetic Thiazolidinediones Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Antidiabetic Thiazolidinediones Sales Volume, by Type (2019-2030)
        3.3.3 Global Antidiabetic Thiazolidinediones Sales Volume, by Type (%) (2019-2030)
    3.4 Global Antidiabetic Thiazolidinediones Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Clinics
        4.1.3 Other
    4.2 Global Antidiabetic Thiazolidinediones Sales Value by Application
        4.2.1 Global Antidiabetic Thiazolidinediones Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Antidiabetic Thiazolidinediones Sales Value, by Application (2019-2030)
        4.2.3 Global Antidiabetic Thiazolidinediones Sales Value, by Application (%) (2019-2030)
    4.3 Global Antidiabetic Thiazolidinediones Sales Volume by Application
        4.3.1 Global Antidiabetic Thiazolidinediones Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Antidiabetic Thiazolidinediones Sales Volume, by Application (2019-2030)
        4.3.3 Global Antidiabetic Thiazolidinediones Sales Volume, by Application (%) (2019-2030)
    4.4 Global Antidiabetic Thiazolidinediones Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Antidiabetic Thiazolidinediones Sales Value by Region
        5.1.1 Global Antidiabetic Thiazolidinediones Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Antidiabetic Thiazolidinediones Sales Value by Region (2019-2024)
        5.1.3 Global Antidiabetic Thiazolidinediones Sales Value by Region (2025-2030)
        5.1.4 Global Antidiabetic Thiazolidinediones Sales Value by Region (%), (2019-2030)
    5.2 Global Antidiabetic Thiazolidinediones Sales Volume by Region
        5.2.1 Global Antidiabetic Thiazolidinediones Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Antidiabetic Thiazolidinediones Sales Volume by Region (2019-2024)
        5.2.3 Global Antidiabetic Thiazolidinediones Sales Volume by Region (2025-2030)
        5.2.4 Global Antidiabetic Thiazolidinediones Sales Volume by Region (%), (2019-2030)
    5.3 Global Antidiabetic Thiazolidinediones Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Antidiabetic Thiazolidinediones Sales Value, 2019-2030
        5.4.2 North America Antidiabetic Thiazolidinediones Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Antidiabetic Thiazolidinediones Sales Value, 2019-2030
        5.5.2 Europe Antidiabetic Thiazolidinediones Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Antidiabetic Thiazolidinediones Sales Value, 2019-2030
        5.6.2 Asia Pacific Antidiabetic Thiazolidinediones Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Antidiabetic Thiazolidinediones Sales Value, 2019-2030
        5.7.2 South America Antidiabetic Thiazolidinediones Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Antidiabetic Thiazolidinediones Sales Value, 2019-2030
        5.8.2 Middle East & Africa Antidiabetic Thiazolidinediones Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Antidiabetic Thiazolidinediones Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Antidiabetic Thiazolidinediones Sales Value
        6.2.1 Key Countries/Regions Antidiabetic Thiazolidinediones Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Antidiabetic Thiazolidinediones Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Antidiabetic Thiazolidinediones Sales Value, 2019-2030
        6.3.2 United States Antidiabetic Thiazolidinediones Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Antidiabetic Thiazolidinediones Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Antidiabetic Thiazolidinediones Sales Value, 2019-2030
        6.4.2 Europe Antidiabetic Thiazolidinediones Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Antidiabetic Thiazolidinediones Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Antidiabetic Thiazolidinediones Sales Value, 2019-2030
        6.5.2 China Antidiabetic Thiazolidinediones Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Antidiabetic Thiazolidinediones Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Antidiabetic Thiazolidinediones Sales Value, 2019-2030
        6.6.2 Japan Antidiabetic Thiazolidinediones Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Antidiabetic Thiazolidinediones Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Antidiabetic Thiazolidinediones Sales Value, 2019-2030
        6.7.2 South Korea Antidiabetic Thiazolidinediones Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Antidiabetic Thiazolidinediones Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Antidiabetic Thiazolidinediones Sales Value, 2019-2030
        6.8.2 Southeast Asia Antidiabetic Thiazolidinediones Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Antidiabetic Thiazolidinediones Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Antidiabetic Thiazolidinediones Sales Value, 2019-2030
        6.9.2 India Antidiabetic Thiazolidinediones Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Antidiabetic Thiazolidinediones Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Sanofi
        7.1.1 Sanofi Company Information
        7.1.2 Sanofi Introduction and Business Overview
        7.1.3 Sanofi Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Sanofi Antidiabetic Thiazolidinediones Product Offerings
        7.1.5 Sanofi Recent Development
    7.2 Takeda Pharmaceuticals
        7.2.1 Takeda Pharmaceuticals Company Information
        7.2.2 Takeda Pharmaceuticals Introduction and Business Overview
        7.2.3 Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Product Offerings
        7.2.5 Takeda Pharmaceuticals Recent Development
    7.3 Eli Lilly
        7.3.1 Eli Lilly Company Information
        7.3.2 Eli Lilly Introduction and Business Overview
        7.3.3 Eli Lilly Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Eli Lilly Antidiabetic Thiazolidinediones Product Offerings
        7.3.5 Eli Lilly Recent Development
    7.4 Merck & Co.
        7.4.1 Merck & Co. Company Information
        7.4.2 Merck & Co. Introduction and Business Overview
        7.4.3 Merck & Co. Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Merck & Co. Antidiabetic Thiazolidinediones Product Offerings
        7.4.5 Merck & Co. Recent Development
    7.5 Novo Nordisk
        7.5.1 Novo Nordisk Company Information
        7.5.2 Novo Nordisk Introduction and Business Overview
        7.5.3 Novo Nordisk Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Novo Nordisk Antidiabetic Thiazolidinediones Product Offerings
        7.5.5 Novo Nordisk Recent Development
    7.6 Bristol-Myers Squibb
        7.6.1 Bristol-Myers Squibb Company Information
        7.6.2 Bristol-Myers Squibb Introduction and Business Overview
        7.6.3 Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Bristol-Myers Squibb Antidiabetic Thiazolidinediones Product Offerings
        7.6.5 Bristol-Myers Squibb Recent Development
    7.7 Pfizer
        7.7.1 Pfizer Company Information
        7.7.2 Pfizer Introduction and Business Overview
        7.7.3 Pfizer Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Pfizer Antidiabetic Thiazolidinediones Product Offerings
        7.7.5 Pfizer Recent Development
    7.8 AstraZeneca
        7.8.1 AstraZeneca Company Information
        7.8.2 AstraZeneca Introduction and Business Overview
        7.8.3 AstraZeneca Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 AstraZeneca Antidiabetic Thiazolidinediones Product Offerings
        7.8.5 AstraZeneca Recent Development
    7.9 GlaxoSmithKline
        7.9.1 GlaxoSmithKline Company Information
        7.9.2 GlaxoSmithKline Introduction and Business Overview
        7.9.3 GlaxoSmithKline Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 GlaxoSmithKline Antidiabetic Thiazolidinediones Product Offerings
        7.9.5 GlaxoSmithKline Recent Development
    7.10 Boehringer Ingelheim
        7.10.1 Boehringer Ingelheim Company Information
        7.10.2 Boehringer Ingelheim Introduction and Business Overview
        7.10.3 Boehringer Ingelheim Antidiabetic Thiazolidinediones Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Boehringer Ingelheim Antidiabetic Thiazolidinediones Product Offerings
        7.10.5 Boehringer Ingelheim Recent Development

 8 Industry Chain Analysis
    8.1 Antidiabetic Thiazolidinediones Industrial Chain
    8.2 Antidiabetic Thiazolidinediones Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Antidiabetic Thiazolidinediones Sales Model
        8.5.2 Sales Channel
        8.5.3 Antidiabetic Thiazolidinediones Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Antidiabetic Thiazolidinediones Market Trends
    Table 2. Antidiabetic Thiazolidinediones Market Drivers & Opportunity
    Table 3. Antidiabetic Thiazolidinediones Market Challenges
    Table 4. Antidiabetic Thiazolidinediones Market Restraints
    Table 5. Global Antidiabetic Thiazolidinediones Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Antidiabetic Thiazolidinediones Revenue Market Share by Company (2019-2024)
    Table 7. Global Antidiabetic Thiazolidinediones Sales Volume by Company (2019-2024) & (K Pcs)
    Table 8. Global Antidiabetic Thiazolidinediones Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Antidiabetic Thiazolidinediones Price by Company (2019-2024) & (USD/Pcs)
    Table 10. Key Manufacturers Antidiabetic Thiazolidinediones Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Antidiabetic Thiazolidinediones Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Antidiabetic Thiazolidinediones
    Table 13. Global Antidiabetic Thiazolidinediones Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antidiabetic Thiazolidinediones as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Antidiabetic Thiazolidinediones Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Antidiabetic Thiazolidinediones Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Antidiabetic Thiazolidinediones Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Antidiabetic Thiazolidinediones Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Antidiabetic Thiazolidinediones Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Antidiabetic Thiazolidinediones Sales Volume by Type: 2019 VS 2023 VS 2030 (K Pcs)
    Table 22. Global Antidiabetic Thiazolidinediones Sales Volume by Type (2019-2024) & (K Pcs)
    Table 23. Global Antidiabetic Thiazolidinediones Sales Volume by Type (2025-2030) & (K Pcs)
    Table 24. Global Antidiabetic Thiazolidinediones Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Antidiabetic Thiazolidinediones Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Antidiabetic Thiazolidinediones Price by Type (2019-2024) & (USD/Pcs)
    Table 27. Global Antidiabetic Thiazolidinediones Price by Type (2025-2030) & (USD/Pcs)
    Table 28. Global Antidiabetic Thiazolidinediones Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Antidiabetic Thiazolidinediones Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Antidiabetic Thiazolidinediones Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Antidiabetic Thiazolidinediones Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Antidiabetic Thiazolidinediones Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Antidiabetic Thiazolidinediones Sales Volume by Application: 2019 VS 2023 VS 2030 (K Pcs)
    Table 34. Global Antidiabetic Thiazolidinediones Sales Volume by Application (2019-2024) & (K Pcs)
    Table 35. Global Antidiabetic Thiazolidinediones Sales Volume by Application (2025-2030) & (K Pcs)
    Table 36. Global Antidiabetic Thiazolidinediones Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Antidiabetic Thiazolidinediones Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Antidiabetic Thiazolidinediones Price by Application (2019-2024) & (USD/Pcs)
    Table 39. Global Antidiabetic Thiazolidinediones Price by Application (2025-2030) & (USD/Pcs)
    Table 40. Global Antidiabetic Thiazolidinediones Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Antidiabetic Thiazolidinediones Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Antidiabetic Thiazolidinediones Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Antidiabetic Thiazolidinediones Sales Value by Region (2019-2024) & (%)
    Table 44. Global Antidiabetic Thiazolidinediones Sales Value by Region (2025-2030) & (%)
    Table 45. Global Antidiabetic Thiazolidinediones Sales Volume by Region (K Pcs): 2019 VS 2023 VS 2030
    Table 46. Global Antidiabetic Thiazolidinediones Sales Volume by Region (2019-2024) & (K Pcs)
    Table 47. Global Antidiabetic Thiazolidinediones Sales Volume by Region (2025-2030) & (K Pcs)
    Table 48. Global Antidiabetic Thiazolidinediones Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Antidiabetic Thiazolidinediones Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Antidiabetic Thiazolidinediones Average Price by Region (2019-2024) & (USD/Pcs)
    Table 51. Global Antidiabetic Thiazolidinediones Average Price by Region (2025-2030) & (USD/Pcs)
    Table 52. Key Countries/Regions Antidiabetic Thiazolidinediones Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Antidiabetic Thiazolidinediones Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Antidiabetic Thiazolidinediones Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Antidiabetic Thiazolidinediones Sales Volume, (2019-2024) & (K Pcs)
    Table 56. Key Countries/Regions Antidiabetic Thiazolidinediones Sales Volume, (2025-2030) & (K Pcs)
    Table 57. Sanofi Company Information
    Table 58. Sanofi Introduction and Business Overview
    Table 59. Sanofi Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 60. Sanofi Antidiabetic Thiazolidinediones Product Offerings
    Table 61. Sanofi Recent Development
    Table 62. Takeda Pharmaceuticals Company Information
    Table 63. Takeda Pharmaceuticals Introduction and Business Overview
    Table 64. Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 65. Takeda Pharmaceuticals Antidiabetic Thiazolidinediones Product Offerings
    Table 66. Takeda Pharmaceuticals Recent Development
    Table 67. Eli Lilly Company Information
    Table 68. Eli Lilly Introduction and Business Overview
    Table 69. Eli Lilly Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 70. Eli Lilly Antidiabetic Thiazolidinediones Product Offerings
    Table 71. Eli Lilly Recent Development
    Table 72. Merck & Co. Company Information
    Table 73. Merck & Co. Introduction and Business Overview
    Table 74. Merck & Co. Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 75. Merck & Co. Antidiabetic Thiazolidinediones Product Offerings
    Table 76. Merck & Co. Recent Development
    Table 77. Novo Nordisk Company Information
    Table 78. Novo Nordisk Introduction and Business Overview
    Table 79. Novo Nordisk Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 80. Novo Nordisk Antidiabetic Thiazolidinediones Product Offerings
    Table 81. Novo Nordisk Recent Development
    Table 82. Bristol-Myers Squibb Company Information
    Table 83. Bristol-Myers Squibb Introduction and Business Overview
    Table 84. Bristol-Myers Squibb Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 85. Bristol-Myers Squibb Antidiabetic Thiazolidinediones Product Offerings
    Table 86. Bristol-Myers Squibb Recent Development
    Table 87. Pfizer Company Information
    Table 88. Pfizer Introduction and Business Overview
    Table 89. Pfizer Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 90. Pfizer Antidiabetic Thiazolidinediones Product Offerings
    Table 91. Pfizer Recent Development
    Table 92. AstraZeneca Company Information
    Table 93. AstraZeneca Introduction and Business Overview
    Table 94. AstraZeneca Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 95. AstraZeneca Antidiabetic Thiazolidinediones Product Offerings
    Table 96. AstraZeneca Recent Development
    Table 97. GlaxoSmithKline Company Information
    Table 98. GlaxoSmithKline Introduction and Business Overview
    Table 99. GlaxoSmithKline Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 100. GlaxoSmithKline Antidiabetic Thiazolidinediones Product Offerings
    Table 101. GlaxoSmithKline Recent Development
    Table 102. Boehringer Ingelheim Company Information
    Table 103. Boehringer Ingelheim Introduction and Business Overview
    Table 104. Boehringer Ingelheim Antidiabetic Thiazolidinediones Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 105. Boehringer Ingelheim Antidiabetic Thiazolidinediones Product Offerings
    Table 106. Boehringer Ingelheim Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Antidiabetic Thiazolidinediones Downstream Customers
    Table 110. Antidiabetic Thiazolidinediones Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Antidiabetic Thiazolidinediones Product Picture
    Figure 2. Global Antidiabetic Thiazolidinediones Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Antidiabetic Thiazolidinediones Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Antidiabetic Thiazolidinediones Sales Volume (2019-2030) & (K Pcs)
    Figure 5. Global Antidiabetic Thiazolidinediones Sales Price (2019-2030) & (USD/Pcs)
    Figure 6. Antidiabetic Thiazolidinediones Report Years Considered
    Figure 7. Global Antidiabetic Thiazolidinediones Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Antidiabetic Thiazolidinediones Players Sales Volume Ranking (2023) & (K Pcs)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Antidiabetic Thiazolidinediones Revenue in 2023
    Figure 10. Antidiabetic Thiazolidinediones Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Rosiglitazone Picture
    Figure 12. Pioglitazone Picture
    Figure 13. Global Antidiabetic Thiazolidinediones Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Antidiabetic Thiazolidinediones Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Antidiabetic Thiazolidinediones Sales Volume by Type (2019 VS 2023 VS 2030) & (K Pcs)
    Figure 16. Global Antidiabetic Thiazolidinediones Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Antidiabetic Thiazolidinediones Price by Type (2019-2030) & (USD/Pcs)
    Figure 18. Product Picture of Hospitals
    Figure 19. Product Picture of Clinics
    Figure 20. Product Picture of Other
    Figure 21. Global Antidiabetic Thiazolidinediones Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Antidiabetic Thiazolidinediones Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Antidiabetic Thiazolidinediones Sales Volume by Application (2019 VS 2023 VS 2030) & (K Pcs)
    Figure 24. Global Antidiabetic Thiazolidinediones Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Antidiabetic Thiazolidinediones Price by Application (2019-2030) & (USD/Pcs)
    Figure 26. North America Antidiabetic Thiazolidinediones Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Antidiabetic Thiazolidinediones Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Antidiabetic Thiazolidinediones Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Antidiabetic Thiazolidinediones Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Antidiabetic Thiazolidinediones Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Antidiabetic Thiazolidinediones Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Antidiabetic Thiazolidinediones Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Antidiabetic Thiazolidinediones Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Antidiabetic Thiazolidinediones Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Antidiabetic Thiazolidinediones Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Antidiabetic Thiazolidinediones Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Antidiabetic Thiazolidinediones Sales Volume (%), (2019-2030)
    Figure 38. United States Antidiabetic Thiazolidinediones Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Antidiabetic Thiazolidinediones Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Antidiabetic Thiazolidinediones Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Antidiabetic Thiazolidinediones Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Antidiabetic Thiazolidinediones Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Antidiabetic Thiazolidinediones Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Antidiabetic Thiazolidinediones Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Antidiabetic Thiazolidinediones Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Antidiabetic Thiazolidinediones Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Antidiabetic Thiazolidinediones Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Antidiabetic Thiazolidinediones Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Antidiabetic Thiazolidinediones Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Antidiabetic Thiazolidinediones Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Antidiabetic Thiazolidinediones Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Antidiabetic Thiazolidinediones Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Antidiabetic Thiazolidinediones Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Antidiabetic Thiazolidinediones Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Antidiabetic Thiazolidinediones Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Antidiabetic Thiazolidinediones Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Antidiabetic Thiazolidinediones Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Antidiabetic Thiazolidinediones Sales Value by Application (%), 2023 VS 2030
    Figure 59. Antidiabetic Thiazolidinediones Industrial Chain
    Figure 60. Antidiabetic Thiazolidinediones Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed

The global market for Antidiabetic Thiazolidinediones was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Antidiabetic Thiazolidinediones, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Antidiabetic Thiazolidinediones by region & country, by Type, and by Application.

The Antidiabetic Thiazolidinediones market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antidiabetic Thiazolidinediones.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Antidiabetic Thiazolidinediones manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Antidiabetic Thiazolidinediones in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Antidiabetic Thiazolidinediones in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.